Mutation Analysis of BRAF, MEK1 and MEK2 in 15 Ovarian Cancer Cell Lines: Implications for Therapy

• Anne L. Estep,

  Affiliation Comprehensive Cancer Center and Cancer Research Institute, University of California at San Francisco, San Francisco, California, United States of America

  ⨯
• Chana Palmer,

  Affiliation Canary Foundation, San Jose, California, United States of America

  ⨯
• Frank McCormick,

  Affiliations Comprehensive Cancer Center and Cancer Research Institute, University of California at San Francisco, San Francisco, California, United States of America, Department of Microbiology and Immunology, University of California at San Francisco, San Francisco, California, United States of America

  ⨯
• Katherine A. Rauen

  *To whom correspondence should be addressed. E-mail: rauen@cc.ucsf.edu

  Affiliations Comprehensive Cancer Center and Cancer Research Institute, University of California at San Francisco, San Francisco, California, United States of America, Department of Pediatrics, University of California at San Francisco, San Francisco, California, United States of America

  ⨯